Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01565330 · ClinicalTrials.gov registry record · Phase 1

A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

A Phase 1 study of Alzheimer Disease, sponsored by Avid Radiopharmaceuticals.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target
3
Study locations

NCT01565330 is a Phase 1 study of Alzheimer Disease that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 20 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01565330, a Phase 1 study of Alzheimer Disease, has completed, sponsored by Avid Radiopharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target
3
Study locations

Study Summary

This study will test two different doses of florbetapir F 18 to determine which dose is best to image amyloid plaques in the brains of Alzheimer's Disease (AD) patients using a positron emission tomography (PET) scanner.

Conditions Studied

Alzheimer Disease

Interventions

  • DRUG florbetapir F 18

Study Locations (3)

Florida

  • Research Site - West Palm Beach

Maryland

  • Research Site - North East

New Jersey

  • Research Site - Clementon

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-03
Est. Completion 2008-08
Phase Phase 1

Sponsor

Avid Radiopharmaceuticals

42 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01565330

The ClinicalTrials.gov registry entry for NCT01565330 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which florbetapir F 18 is the first listed.

NCT01565330 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Maryland, New Jersey.

Frequently Asked Questions

What is clinical trial NCT01565330 about?

NCT01565330 is a clinical study titled "A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers". This study will test two different doses of florbetapir F 18 to determine which dose is best to image amyloid plaques in the brains of Alzheimer's Disease (AD) patients using a positron emission tomography (PET) scanner.

What is the current status of trial NCT01565330?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-03. Estimated completion is 2008-08.

What conditions does trial NCT01565330 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT01565330?

The interventions under investigation include: florbetapir F 18 (DRUG).

Who is sponsoring clinical trial NCT01565330?

This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01565330 being conducted?

This trial has 3 study locations across Florida, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.